Scientific symposium on vaccination against influenza: Kemi, Finland, 22 March 2002ZAMBON, Maria; WOOD, John M.Vaccine. Supplement. 2002, Vol 20, issn 1359-5938, 56 p., 5Conference Proceedings

From basic research to the bedside : efficacy of topical treatment with pseudocatalase PC-KUS in 71 children with vitiligoSCHALLREUTER, Karin U; KRÜGER, Christian; WIIRFEL, Brigitte A et al.International journal of dermatology. 2008, Vol 47, Num 7, pp 743-753, issn 0011-9059, 11 p.Article

Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with Nonadjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine : A potential priming strategy. CommentarySCHWARTZ, Benjamin; GELLIN, Bruce; STEPHENSON, Iain et al.The Journal of infectious diseases. 2005, Vol 191, Num 8, pp 1207-1209, issn 0022-1899, 9 p.Article

Production of influenza virus in serum-free mammalian cell culturesMERTEN, O.-W; MANUGUERRA, J.-C; HANNOUN, C et al.Developments in biological standardization. 1999, Num 98, pp 23-37, issn 0301-5149Conference Paper

ICH guidelines and PhEur monographs on derivation and characterisation of cell substrates used for production of biotechnological/biological productsDOBBELAER, R.Developments in biological standardization. 1999, Num 98, pp 159-165, issn 0301-5149Conference Paper

Suitability of MDCK cells grown in a serum-free medium for influenza virus productionKESSLER, N; THOMAS-ROCHE, G; GERENTES, L et al.Developments in biological standardization. 1999, Num 98, pp 13-21, issn 0301-5149Conference Paper

Comparison of neutralising antibody assays for detection of antibody to influenza A/H3N2 viruses : An international collaborative studySTEPHENSON, Iain; GAINES DAS, Rose; WOOD, John M et al.Vaccine. 2007, Vol 25, Num 20, pp 4056-4063, issn 0264-410X, 8 p.Article

Oestrogenic compounds and oxidative stress (in human sperm and lymphocytes in the Comet assay)ANDERSON, Diana; SCHMID, Thomas E; BAUMGARTNER, Adolf et al.Mutation research. Reviews in mutation research. 2003, Vol 544, Num 2-3, pp 173-178, issn 1383-5742, 6 p.Conference Paper

Cellular immune responses to influenzaMOSS, P.Developments in biologicals. 2003, Vol 115, pp 31-37, issn 1424-6074, 7 p.Conference Paper

Flow cytometric measurement of intracellular IFN-γ induction in aged subjects before and after parenteral influenza vaccinationFRINGUELLI, E; LEPRI, E; CAMILLONI, B et al.Developments in biologicals. 2003, Vol 115, pp 55-59, issn 1424-6074, 5 p.Conference Paper

Using the strains and getting the vaccine licensed: A vaccine manufacturer's viewGERDIL, C.Developments in biologicals. 2003, Vol 115, pp 17-21, issn 1424-6074, 5 p.Conference Paper

Influvac^TC : A safe Madin Darby Canine Kidney (MDCK) cell culture-based influenza vaccineBRANDS, R; VISSER, J; MEDEMA, J et al.Developments in biological standardization. 1999, Num 98, pp 93-100, issn 0301-5149Conference Paper

Safety and antigenicity of whole virus and subunit influenza A/Hong Kong/1073/99 (H9N2) vaccine in healthy adults: phase I randomised trialSTEPHENSON, Lain; NICHOLSON, Karl G; GLÜCK, Reinhardt et al.Lancet (British edition). 2003, Vol 362, Num 9400, pp 1959-1966, issn 0140-6736, 8 p.Article

Haemagglutination-inhibiting antibody to influenza virusDE JONG, J. C; PALACHE, A. M; BEYER, W. E et al.Developments in biologicals. 2003, Vol 115, pp 63-73, issn 1424-6074, 11 p.Conference Paper

Immune correlates of protection against influenza in the human challenge modelTREANOR, J; WRIGHT, R. F.Developments in biologicals. 2003, Vol 115, pp 97-104, issn 1424-6074, 8 p.Conference Paper

An overview of host cell selectionROBERTSON, J. S.Developments in biological standardization. 1999, Num 98, pp 7-11, issn 0301-5149Conference Paper

A phase I, randomized controlled clinical trial to study the reactogenicity and immunogenicity of a new split influenza vaccine derived from a non-tumorigenic cell linePERCHESON, P. B; TREPANIER, P; DUGRE, R et al.Developments in biological standardization. 1999, Num 98, pp 127-132, issn 0301-5149Conference Paper

Cell culture influenza vaccine : An Australian perspectiveCHANG, L; CRICHTON, R; NANDAPALAN, P et al.Developments in biological standardization. 1999, Num 98, pp 177-181, issn 0301-5149Conference Paper

Inactivated influenza vaccines prepared in cell cultureBROWN, Fred; ROBERTSON, James S; SCHILD, Geoffrey C et al.Developments in biological standardization. 1999, Num 98, issn 0301-5149, 214 p.Conference Proceedings

The influence of the host cell on standardisation of influenza vaccine potencyWOOD, J. M; DUNLEAVY, U; NEWMAN, R. W et al.Developments in biological standardization. 1999, Num 98, pp 183-188, issn 0301-5149Conference Paper

Safety and immunogenicity of whole-virus, alum-adjuvanted whole-virus, virosomal, and whole-virus intradermal influenza A/H9N2 vaccine formulationsNICHOLSON, Karl G; THOMPSON, Catherine I; KLAP, Jaco M et al.Vaccine. 2010, Vol 28, Num 1, pp 171-178, issn 0264-410X, 8 p.Article

Methionine Sulfoxide Reductases A and B Are Deactivated by Hydrogen Peroxide (H₂O₂) in the Epidermis of Patients with VitiligoSCHALLREUTER, Karin U; RÜBSAM, Katharina; GIBBONS, Nicholas C. J et al.Journal of investigative dermatology. 2008, Vol 128, Num 4, pp 808-815, issn 0022-202X, 8 p.Article

Estrogens can contribute to hydrogen peroxide generation and quinone-mediated DNA damage in peripheral blood lymphocytes from patients with vitiligoSCHALLREUTER, Karin U; CHIUCHIARELLI, Georgia; ANDERSON, Diana et al.Journal of investigative dermatology. 2006, Vol 126, Num 5, pp 1036-1042, issn 0022-202X, 7 p.Article

UVA-induced modification of catalase charge properties in the epidermis is correlated with the skin phototype. CommentaryWOOD, John M; SCHALLREUTER, Karin U; MARESCA, Vittoria et al.Journal of investigative dermatology. 2005, Vol 126, Num 1, pp 13-14, issn 0022-202X, 11 p.Article

InfluenzaNICHOLSON, Karl G; WOOD, John M; ZAMBON, Maria et al.Lancet (British edition). 2003, Vol 362, Num 9397, pp 1733-1745, issn 0140-6736, 13 p.Article